René Delosh

460 total citations
10 papers, 347 citations indexed

About

René Delosh is a scholar working on Molecular Biology, Oncology and Biotechnology. According to data from OpenAlex, René Delosh has authored 10 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Biotechnology. Recurrent topics in René Delosh's work include Cancer Research and Treatments (3 papers), Protein Degradation and Inhibitors (3 papers) and Cancer Cells and Metastasis (2 papers). René Delosh is often cited by papers focused on Cancer Research and Treatments (3 papers), Protein Degradation and Inhibitors (3 papers) and Cancer Cells and Metastasis (2 papers). René Delosh collaborates with scholars based in United States, Malaysia and Ukraine. René Delosh's co-authors include Julie Laudeman, Russell Reinhart, Thomas Silvers, Beverly A. Teicher, David M. Evans, Anne Monks, Michael Selby, Erik Harris, Joel Morris and John Connelly and has published in prestigious journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

René Delosh

10 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
René Delosh United States 7 205 190 83 78 41 10 347
Julie Laudeman United States 6 184 0.9× 162 0.9× 56 0.7× 49 0.6× 43 1.0× 9 313
Thomas Silvers United States 7 198 1.0× 177 0.9× 61 0.7× 49 0.6× 54 1.3× 14 334
Russell Reinhart United States 6 181 0.9× 168 0.9× 61 0.7× 47 0.6× 46 1.1× 9 298
Chune Yu China 10 236 1.2× 181 1.0× 60 0.7× 117 1.5× 32 0.8× 15 413
Touko Inao Japan 12 184 0.9× 280 1.5× 71 0.9× 106 1.4× 28 0.7× 20 495
Shaocong Wu China 10 255 1.2× 199 1.0× 80 1.0× 130 1.7× 26 0.6× 14 454
Axel-Rainer Hanauske Germany 8 266 1.3× 209 1.1× 88 1.1× 58 0.7× 65 1.6× 17 494
Kaamar Azijli Netherlands 10 325 1.6× 161 0.8× 53 0.6× 106 1.4× 43 1.0× 13 465
Caroline Coghlin United Kingdom 6 205 1.0× 185 1.0× 106 1.3× 134 1.7× 18 0.4× 10 447

Countries citing papers authored by René Delosh

Since Specialization
Citations

This map shows the geographic impact of René Delosh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by René Delosh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites René Delosh more than expected).

Fields of papers citing papers by René Delosh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by René Delosh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by René Delosh. The network helps show where René Delosh may publish in the future.

Co-authorship network of co-authors of René Delosh

This figure shows the co-authorship network connecting the top 25 collaborators of René Delosh. A scholar is included among the top collaborators of René Delosh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with René Delosh. René Delosh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Delosh, René & Robert H. Shoemaker. (2021). Evaluation of Real-Time In Vitro Invasive Phenotypes. Methods in molecular biology. 2294. 165–180. 1 indexed citations
2.
Evans, David M., Jianwen Fang, Thomas Silvers, et al.. (2019). Exposure time versus cytotoxicity for anticancer agents. Cancer Chemotherapy and Pharmacology. 84(2). 359–371. 22 indexed citations
3.
Delosh, René, Julie Laudeman, Russell Reinhart, et al.. (2017). 3D Models of the NCI60 Cell Lines for Screening Oncology Compounds. SLAS DISCOVERY. 22(5). 473–483. 55 indexed citations
4.
Teicher, Beverly A., Thomas Silvers, Michael Selby, et al.. (2017). Small cell lung carcinoma cell line screen of etoposide/carboplatin plus a third agent. Cancer Medicine. 6(8). 1952–1964. 16 indexed citations
5.
Polley, Eric C., Mark W. Kunkel, David M. Evans, et al.. (2016). Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression. JNCI Journal of the National Cancer Institute. 108(10). djw122–djw122. 106 indexed citations
6.
Teicher, Beverly A., Eric C. Polley, Mark W. Kunkel, et al.. (2015). Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression. Molecular Cancer Therapeutics. 14(11). 2452–2462. 55 indexed citations
7.
August, Elias, René Delosh, Julie Laudeman, et al.. (2013). Abstract 5590: Screening of pediatric and adult sarcoma cell lines reveals novel patterns of sensitivity toward approved oncology drugs and investigational agents.. Cancer Research. 73(8_Supplement). 5590–5590. 1 indexed citations
8.
Monks, Anne, David M. Evans, Thomas Silvers, et al.. (2013). Abstract C103: Sarcoma cell line sensitivity towards approved oncology drugs and investigational agents identifies distinct patterns of response which can be interrogated with associated gene expression.. Molecular Cancer Therapeutics. 12(11_Supplement). C103–C103. 1 indexed citations
9.
Saini, Vaibhav, Curtis Hose, Anne Monks, et al.. (2012). Identification of CBX3 and ABCA5 as Putative Biomarkers for Tumor Stem Cells in Osteosarcoma. PLoS ONE. 7(8). e41401–e41401. 70 indexed citations
10.
Saini, Vaibhav, Curtis Hose, Anne Monks, et al.. (2012). Correction: Identification of CBX3 and ABCA5 as Putative Biomarkers for Tumor Stem Cells in Osteosarcoma. PLoS ONE. 7(11). 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026